Sponsor or institution
Clinical trials and research at BrightGene Bio-Medical Technology Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by BrightGene Bio-Medical Technology Co., Ltd. that are recruiting, in China. By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
BGM0504 vs. semaglutide in Chinese adults with obesity-related T2DM
In Chinese adults with type 2 diabetes and obesity who aren’t well controlled by diet and exercise, this trial tests BGM0504 injections once a week for 52 weeks against semaglutide to see which helps more with blood sugar, weight, and safety, including whether diabetes stays in remission after stopping treatment.
-
Weight loss pill (BGM0504) in adults who are overweight or obese, without diabetes
This trial tests whether BGM0504 tablets help overweight or obese adults without diabetes lose weight compared with a placebo over 20 weeks.
Quick answers
How many clinical trials run by BrightGene Bio-Medical Technology Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.